Diagnostic performance of dipyridamole SPECT MPI
| Author | Number of patients | Tracer | Analysis | MI excluded | Quality | Sensitivity | Specificity |
|---|---|---|---|---|---|---|---|
| *Values were calculated for patients with and without myocardial infarction, values shown include those with myocardial infarction; †coronary stenosis ⩾70%. | |||||||
| Sensitivity and specificity values for coronary stenosis ⩾50% and for coronary stenosis ⩾70%. Quality is rated according to the number of quality criteria (adequate description of study group, avoidance of verification bias, avoidance of diagnostic and test review bias) met. | |||||||
| MI, myocardial infarction; mibi, technetium-99m sestamibi; Q, quantitative analysis; tetro, technetium-99m tetrofosmin; Tl-201, thallium-201; uns, unspecified; V, visual analysis. | |||||||
| †Francisco 198224 | 75 | Tl-201 | Q | no | Medium | 90% | 96% |
| †Huikuri 198825 | 93 | Tl-201 | V | no | Medium | 96% | 75% |
| Go 199026 | 202 | Tl-201 | V | *both | High | 76% | 80% |
| †Mendelson 199227 | 79 | Tl-201 | V | *both | Medium | 90% | – |
| Cramer 199428 | 38 | Tl-201 | V | No | High | 90% | 71% |
| Grover-McKay 199413 | 18 | Tl-201 | V | uns | Low | 91% | 100% |
| Ho 199529 | 54 | Tl-201 | V | no | High | 98% | 73% |
| Watanabe 199730 | 53 | Tl-201 | V | yes | Medium | 80% | 72% |
| Tartagni 199131 | 30 | Tl-201; mibi | V | no | Medium | 100% | 75% |
| Miller 199732 | 244 | Mibi | V | *both | Medium | 91% | 28% |
| Schillaci 199733 | 40 | Mibi | V | yes | Low | 95% | 72% |
| Soman 1997 34] | 27 | Mibi | V | no | High | 90% | 66% |
| Ogilby 199835 | 26 | Mibi | V | no | Medium | 90% | 100% |
| †Santoro 199836 | 60 | Mibi | V | yes | High | 97% | 89% |
| He 199737 | 64 | Tetro | V | no | Medium | 85% | 54% |